Outcomes of Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation by Using a Standard Myeloablative versus a Novel Reduced-Toxicity Conditioning Regimen According to a New Risk Stratification

Improving outcomes among class 3 thalassemia patients receiving allogeneic hematopoietic stem cell transplantations (HSCT) remains a challenge. Before HSCT, patients who were ≥ 7 years old and had a liver size ≥ 5 cm constitute what the Center for International Blood and Marrow Transplant Research d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Anurathapan, Usanarat, Pakakasama, Samart, Mekjaruskul, Pimsiri, Sirachainan, Nongnuch, Songdej, Duantida, Chuansumrit, Ampaiwan, Charoenkwan, Pimlak, Jetsrisuparb, Arunee, Sanpakit, Kleebsabai, Pongtanakul, Bunchoo, Rujkijyanont, Piya, Meekaewkunchorn, Arunotai, Sruamsiri, Rosarin, Ungkanont, Artit, Issaragrisil, Surapol, Andersson, Borje S., Hongeng, Suradej
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5538782/
https://ncbi.nlm.nih.gov/pubmed/25064743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.07.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados